Data as of 3:59pm ET
| +0.19 / +1.90%|
The 5 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 25.00, with a high estimate of 38.00 and a low estimate of 22.00. The median estimate represents a +145.34% increase from the last price of 10.19.
The current consensus among 6 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.